je.st
news
Investors short Juno Therapeutics, Amgen stocks, but that may not be bad news
2015-03-03 04:12:21| Biotech - Topix.net
More investors were shorting their biotech stocks in the first half of February than in the previous month, according to financial news site Benzinga . Of the top three companies with the most short sells, two have Puget Sound ties: Seattle-based Juno Therapeutics and California-based Amgen , which has offices in Bothell and Seattle until the end of the year.
Tags: news
short
bad
stocks
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||